By means of a questionnaire. an attempt was made to assess the quality of performance and interpretation of the oral glucose tolerance test by laboratories participating in the UK External Quality Assessment Scheme for Clinical Chemistry. The results showed a general awareness of current recommendations in terms of both protocol for the test and criteria for interpretation of results. but some deficiencies were observed in both these areas and in some case deviations in protocol may have been sufficient to invalidate comparison of results with currently recommended criteria for interpretation of the test.
An individual's ability to dispose of an ingested glucose load has traditionally been. and still is. the definitive test for the purpose of diagnosing diabetes mellitus. although in many cases the diagnosis can be made on the basis of fasting or random plasma glucose measurements without subjecting the patient to a glucose tolerance test (GTT). Nevertheless, substantial numbers of GTTs are carried out by clinical biochemistry departments. specialist diabetic units and sometimes by hospital ward staff.
In recent years there have been attempts to achieve national and international standardisation of the performance and interpretation of the GTTI, 2. 3 and the category of 'impaired glucose tolerance' has been introduced to denote a condition intermediate between diabetic and normal responses. As this is not necessarily prognostic for diabetes. individuals so classified should not be subjected to all the social. legal and financial restrictions associated with diabetes. Hence, correct classification is important.
It was with this in mind that the Quality Assurance Working Party of the Scientific Committee of the Association of Clinical Biochemists set about assessing the quality of performance of the GTT both in terms of Prepared at the request of the Quality Assurance Working Party. Scientific Committee, Association of Clinical Biochemists. The statements made herein do not necessarily reflect the views of the Committee. technical procedure and ability to interpret the results obtained. Result'! About ZOO of the 550 questionnaire forms were returned by the end of March and about 30 late replies were received. In addition to United Kingdom NBS laboratories. replies came from private laboratories. from several hospital laboratories in Eire. one from Germany and a few from veterinary laboratories.
Two hundred and nine of the 230 respondents said they carried out OTTs in their establishments. but the number of tests done varied greatly from about one per year to 30 per week. giving an average figure of about five per week per laboratory. This takes no account of size of laboratory or population served but the average figure is probably reasonably representative of a District General Hospital.
Whilst few laboratories were rigidly insistent upon patients having a preliminary fasting or random glucose measurement before proceeding with a GTT, the majority encouraged preliminary screening, at least in theory.
PREPARATION OF PATIENT

Fasting period
Eighty two per cent of laboratories fasted patients for between 9 and 14 h and a few (1·4%) extended this up to 16 h. However, 6'¥0 used a fasting period of only 5 to 9 hand 10% simply specified 'overnight fasting'.
Fluids during fasting
Water was usually allowed during fasting, but the amount was restricted in 3°;', of laboratories (3 allowed only one glass and 4 others 'sips' or 'small amounts'). Moreover, 6% of laboratories allowed no fluids at all, whereas limited amounts of tea or coffee, usually one cup, without milk or sugar, were permitted by 29%.
Carbohydrate intake prior to fasting Although 43% of laboratories made no recommendation about dietary preparation for the test, 44% stipulated a 'normal diet' for 3 or 4 days before the test and 13% specified a minimum carbohydrate intake, ranging from 100 g to 30() g per day over the 3 days prior to fasting.
Starting time
In 93% of cases, glucose was administered at about 0900h, but there were six instances (3%) where in-patient GTTs were started between 0530 and 0630 h.
Quantity of glucose given
Eighteen per cent of laboratories were using a 50 g glucose load and the rest 75 g but three of the former group said they were changing to 75 g.
Molecular species of glucose given
Although rather more than 5()% of participants claimed to be using glucose monohydrate and the rest the anhydrous form, this question revealed so much uncertainty and confusion that the validity of some of the answers was in doubt.
Form in which glucose administered
In most cases the glucose load was prepared by Only 50% of laboratories stated the volume of Hycal or Lucozade used, but of those that did, between 105 mL and ISO mL of Hycal was used to provide a 75 g load (manufacturer's recommendation-lOS mL is equivalent to 75 g glucose monohydrate). Similar variation was noted in the volumes of Lucozade employed (318 mL to 370 mL) compared with the manufacturer's recommendation of 353 mL.
Smoking
Only 5% of laboratories allowed smoking during the test and 12% prohibited it entirely on the morning of the test.
Exercise
Twenty-four per cent of laboratories did not restrict exercise during the test but the remainder attempted to ensure that the patient sat quietly during this period. A small number arranged for the patient to be recumbent. Three per cent recommended normal, but not excessively energetic, exercise for several days prior to the test.
Urine specimens
Eighty-seven per cent of laboratories collected urine specimens. In some cases the patient was asked to bring an early morning urine, in others a fasting specimen was collected before the start of the test and subsequent samples were col-lected at 1 hand 2 h after glucose. However. 18% of those collecting urines did so halfhourly. Most tested for glucose using specific dipstick tests and a smaller number tested for reducing substances. either instead of or as well as for glucose. About 50% of the laboratories tested for ketones.
Blood specimens
Although there were some differences in the numbers of blood samples collected (between two and seven were collected at times up to 3 h after glucose administration). 78% of laboratories collected five or six at half-hourly intervals up to 2 or 21f2 h. Twenty-two per cent collected only two or three blood samples-fasting and at 2 h, and in most cases also at I h.
Sixty-two per cent of laboratories used venous blood and the rest used capillarysamples. usually from finger or thumb. but occasionally from ear lobe. Skin preparation was usually by alcohol swab. but some used chlorhexidine and a few used no skin preparation. For the glucose estimation. 36% of laboratories used whole blood and the rest used plasma. The decision was largely influenced by the method employed for glucose analysis and it is noteworthy that all except one laboratory were using enzymic glucose assays that show good specificity for glucose. Another laboratory was using a test strip and reflectance meter method. but the remainder were employing what would be regarded as 'laboratory' methods.
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Questionnaire on performance and interpretation of glucose tolerance tests for the diagnosis of diabetes mellitus. mented on or offered interpretations on GTI reports, but to some extent this depended on who had requested the investigation. For example, reports to general practitioners were often accompanied by an interpretation. Most of those who did not routinely comment were prepared to do so if asked and the majority of laboratories had some guidelines for interpretation, usually based on World Health Organisation (WHO),I British Diabetic Association' or National Diabetes Data Group (NDDG)3 information.
Approximately 180 participants (86% of laboratories performing GTI offered interpretations for the four specimen GTIs provided in the questionnaire (Fig. I) , the 'correct' answers, based mainly on WHO (l980) criteria' were considered to be: Case I. Normal or non-diabetic. Case 2. 'Lag storage' type non-diabetic. Case 3. Impaired glucose tolerance. Case 4. Consistent with diabetes mellitus.
Note. WHO criteriaI for diagnosis of diabetes mellitus using venous plasma are a fasting glucose level equal to or greater than g·O mmoVL and/or a 2 h level equal to or greater than 11·0 mmoVL following a 75 g oral glucose load.
For a diagnosis of impaired glucose tolerance. the criteria are a fasting level less than g·O mmoVL and a 2 h level equal to or greater than 8·0 mmoVL but less than 11·0 mmoVL.
Actual findings. Case 1. One hundred and thirty participants (72%) said the result was normal or possibly normal. Some suggested repeating the test. Thirty-four (19%) thought it showed impaired glucose tolerance and three said it was a diabetic curve, two classifying it as mild. The remaining answers were noncommittal. Case 2. One hundred and fifty-two (84%) classified Case 2 as normal or 'lag' type, some suggesting possible causes and further investigations. Sixteen (9%) reported it as impaired tolerance and three said it was mildly diabetic. Case 3. One hundred and fifty-five (86%) classified it as impaired or diminished tolerance, two as diabetic and 14 (8%) as normal. Case 4. One hundred and sixty-five (92%) said Case 4 was diabetic or 'mildly diabetic' or 'probably diabetic'. Fourteen (8%) said it showed impaired glucose tolerance and no one thought it was normal.
The results from 76 laboratories that normally added comments to GTI reports were extracted from the above and analysed in the same way. but produced a virtually identical pattern to the replies from all laboratories shown above.
Discussion
There are considerable differences in protocol between laboratories performing the GTI. some preparing the patient inadequately and others appearing to be unnecessarily restrictive. For example, as there seems to be no evidence that water taken freely is detrimental to the test. restriction appears to be an unnecessary imposition on the patient. On the other hand. in a few instances patients' food intake seemed to be stopped for an insufficiently long period prior to the test.
The NDDG recommends overnight fasting for 10 to 16 h and the WHO lO to 14 hand water is permitted during this period. A normal unrestricted diet containing at least 150 g of carbohydrate is advised for at least 3 days prior to the test.
It is evident that there is considerable ignorance about the form and amount of glucose being administered. Probably most laboratories are using the monohydrate but many think they are giving the anhydrous form and even those using commercial liquid preparations do not all use the same volume despite advice on this being available from the manufacturer.
-Most hospital laboratories employing powdered glucose probably obtain it from their pharmacy departments. already weighed out and as the usual British Pharmacopoeia preparation is the monohydrate of molecular weight 198, that is the form most likely to be used. The anhydrous form has a molecular weight of 180 and this means that a load of anhydrous glucose contains about to'Yo more glucose than a similar weight of the monohydrate. In practice. a difference of 10% at the level of a 75 g load may not make a significant difference to an individual's glycaemic response but any 'looseness' of protocol such as this is likely to detract from the diagnostic ability of the test. The national and international organisations involved in the study of diabetes do not appear to offer any guidance on this matter. but as the monohydrate is the most readily available form, it would seem reasonable to standardise on a 75 g load of glucose monohydrate (dextrose monohydrate).
Of the commercial liquid preparations. Hycal and Lucozade are not simple glucose solutions; much of the glucose is in polysaccharide form, but they are considered to perform acceptably in the GTI. 1 They have the advantage that they are less sweet than simple glucose solutions and therefore less likely to cause nausea. However. Lucozade does contain caffeine and there is some evidence that moderate amounts of coffee or caffeine can raise an individual's plasma glucose level•.J· 5 although these studies were performed with higher doses of caffeine than would be contained in a Lucozade load in the GTI. In view of this possible effect, it also seems prudent to prohibit caffeine-containing beverages during the fasting period.
The division of individuals into. groups according to differing degrees of glucose tolerance is a somewhat arbitrary classification but the currently recommended criteria arc based on acquired clinical experience with respect to prognosis and risk associated with various levels of glucose intolerance. It is. therefore, important to have a uniform method for assessing patients.
Although Case I in this survey had results within normal limits according to WHO (l980) criteria. I 19% of laboratories classified it as impaired glucose tolerance and, even more worrying, three said it was diabetic. Case 2 was also misclassified by nearly II % as showing impaired glucose tolerance or even mild diabetes. However, Case 3 was correctly classified by 86% as impaired glucose tolerance, suggesting that most people are aware of this relatively new intermediate classification. As Case 4 was frankly consistent with diabetes. it would have been disappointing if most people had not classified it correctly.
It seems, therefore. that there is a general awareness of the currently recommended criteria for interpretation of the glucose tolerance test. but that these arc not always applied correctly. leading to potential misclassification of an individual wit': life-long social. financial and legal implications for that person.
Notwithstanding most laboratories being aware of WHO criteria for interpretation. some respondents used non-standard terminology when offering interpretation of the results provided. For example. impaired glucose tolerance was sometimes referred to as 'diminished tolerance' and the diabetic curve similarly or as 'severe diminished tolerance'. This seemed to reveal a cautious attitude on the part of a few laboratories, and an unwillingness to make an unambiguous statement in case they were wrong. Whilst this is understandable up to a point. it must be remembered that the whole purpose of the test is to achieve. where possible. a clear unambiguous categorisation of the patient.
It is particularly important that whoever interprets the results of a GTI knows what type of specimen was collected (capillary or venous blood) and whether whole blood or plasma was analysed. The WHO' provides different criteria for several different types of blood sample but no figures are given for capillary plasma. which was used by 21 laboratories in this survey (i.e. about 10%) and capillary plasma will in some cases yield higher values than venous plasma samples. This sort of consideration is especially relevant when results are sent to clinicians for them to interpret themselves and often they are left in ignorance of the laboratory's methods. A more recent WHO report (1985t corrects the earlier omission and offers guidance on capillary plasma results. but many laboratories are probably still unaware of its existence. This survey was conducted in an attempt to assess the quality of performance of the OTI. one of the commonest and oldest dynamic function tests-a test that tends to be taken for granted because it is so well established and so familiar. Disorders of glucose tolerance are so common that the GTI cannot be regarded as a specialist test as some other dynamic function tests are. It is used by diabetologists, general physicians. surgeons. obstetricians. general practitioners and others. As non-specialists in diabetes may be unaware of the nuances of the test and the influence of protocol and analytical details. guidance is required and the onus is on the laboratory to provide this.
In clinical practice. the validity of the interpretation of results of the GTI is partly dependent on the soundness of the protocol. but this study attempted to separate the two and deficiencies were revealed in both areas. In order to make optimal use of internationally recommended criteria for interpretation of results it is essential that laboratories attempt to standardise protocols as much as possible and to apply assessment criteria that are most appropriate to the type of specimen and method of analysis.
A small number of laboratories showed sufficient deviation in protocol to cast doubt on the validity of comparison of results with such criteria as WHO.' On the other hand there was clear evidence that many laboratories are making determined efforts to achieve uniformity of performance and interpretation of the GTI.
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It is a pity that more laboratories did not return the questionnaire. despite a reminder being issued. but one can only speculate as to the reasons for this. Presumably some had no practical interest in the GTI and others either ignored the questionnaire or forgot it. but it is likely that some felt unable or unwilling to answer the questions and unfortunately this might characterise a group providing a poorer GTI service than those prepared to answer the questions. There were also some single replies that represented the views of more than one laboratory receiving the questionnaire.
Although some previous attempts have been made to assess the quality of interpretative aspects of chemical pathology tests. it is generally a neglected area. Despite a very small number of adverse reactions to the study. most comments have been favourable and it appears to have stimulated some participants to reexamine their own procedures.
One difficulty with this type of survey is that replies are subjective to the extent that interpretations depend on the judgements of individuals and it is not easy to decide who should receive the questionnaire to ensure that cases are given neither more nor less expert attention than they would normally receive. In this survey. the questionnaire was sent to persons nominated by their laboratories for liaison with the UK EQAS and it was hoped that communication within laboratories would be good enough to ensure that the questionnaire reached the most appropriate person. but in a few instances it seems that this may not have happened. Despite these reservations. the ACB Quality Assurance Working Party is currently considering whether other areas of clinical biochemistry could profitably be studied in a similar way.
